CMG Pharmaceutical Co., Ltd. (058820.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap274.69B
Enterprise Value340.58B
P/E Ratio9.7
PEG Ratio0.02
Price/Sales Ratio0.49
Price/Book Ratio0.28
Enterprise/Revenue0.98
Enterprise/EBITDA27.04

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.05
Operating Margin-0.03
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue105.23B
Revenue/Share7,823.11
Gross Profit59.45B
EBITDA-610.42M
Net Income-8.96B
Diluted EPS-606.3

Balance Sheet

Total Cash17.75B
Total Cash/Share1,199.75
Total Debt68.7B
Total Debt/Equity0.34
Current Ratio1.17
Book Value Per Share13,812.8

Price History

52-Week Change-78.9
52-Week High22,050
52-Week Low3,590
Moving Average 50 Days5,348.1
Moving Average 200 Days11,448.63

Statistics

Average Volume74,641
Shares Outstanding14.81M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateOctober 27, 2026
AD